SEIKAGAKU CORPORATION

4548

TSE PrimePharmaceuticals

¥ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement (PL) Summary

Updated: 2026-08-05FY2027 Q1

Revenue

367.5100M JPY

YoY -3.5%

Operating Income

-9.4100M JPY

YoY -158.4%

Net Income

16.6100M JPY

YoY +287.4%

EPS

-0.2JPY

YoY +94.3%

Performance Trend

Revenue, operating income and net income trend (last 5 periods)

RevenueOperatingNet Income

393.7億円

293.7億円

193.6億円

93.5億円

-6.6億円

Rev: 348.5億円Op: 45億円NI: 37.3億円

Rev: 334.6億円Op: 21.1億円NI: 22.4億円

Rev: 362.1億円Op: 4.3億円NI: 21.9億円

Rev: 393.7億円Op: 13.3億円NI: 12.1億円

Rev: 366.4億円Op: -6.6億円NI: 14.7億円

2022/FY2023/FY2024/FY2025/FY2026/FY

Full-Year Progress

FY2027 Q1

Net Income0%

Revenue Progress88.300M

Revenue Forecast418.500M

Net Income Progress-11M

Net Income Forecast22.500M

Income Statement Details

Unit: JPY

Unlock Long-Term Financial Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan